Rigter GM - Search Results

1

Rat C-reactive protein activates the autologous complement system.

Diaz Padilla N, Bleeker WK, Lubbers Y, Rigter GM, Van Mierlo GJ, Daha MR, Hack CE. Diaz Padilla N, et al. Among authors: rigter gm. Immunology. 2003 Aug;109(4):564-71. doi: 10.1046/j.1365-2567.2003.01681.x. Immunology. 2003. PMID: 12871224 Free PMC article.

2

The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model.

Bos IG, van Mierlo GJ, Bleeker WK, Rigter GM, te Velthuis H, Dickneite G, Hack CE. Bos IG, et al. Among authors: rigter gm. Int Immunopharmacol. 2001 Aug;1(8):1583-95. doi: 10.1016/s1567-5769(01)00073-x. Int Immunopharmacol. 2001. PMID: 11515821

3

Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model.

Teeling JL, Bleeker WK, Rigter GM, van Rooijen N, Kuijpers TW, Hack CE. Teeling JL, et al. Among authors: rigter gm. Br J Haematol. 2001 Mar;112(4):1031-40. doi: 10.1046/j.1365-2141.2001.02674.x. Br J Haematol. 2001. PMID: 11298603 Free article.

4

Key role of macrophages in hypotensive side effects of immunoglobulin preparations. Studies in an animal model.

Bleeker WK, Agterberg J, Rigter G, van Rooijen N, Bakker JC. Bleeker WK, et al. Clin Exp Immunol. 1989 Sep;77(3):338-44. Clin Exp Immunol. 1989. PMID: 2805404 Free PMC article.

5

Clearance of human factor XIa-inhibitor complexes in rats.

Wuillemin WA, Bleeker WK, Agterberg J, Rigter G, ten Cate H, Hack CE. Wuillemin WA, et al. Br J Haematol. 1996 Jun;93(4):950-4. doi: 10.1046/j.1365-2141.1996.d01-1740.x. Br J Haematol. 1996. PMID: 8703832

6

Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase.

Bleeker WK, Teeling JL, Verhoeven AJ, Rigter GM, Agterberg J, Tool AT, Koenderman AH, Kuijpers TW, Hack CE. Bleeker WK, et al. Among authors: rigter gm. Blood. 2000 Mar 1;95(5):1856-61. Blood. 2000. PMID: 10688848 Free article.

7

Evaluation of the immunogenicity of polymerized hemoglobin solutions in a rabbit model.

Bleeker WK, Zappeij LM, den Boer PJ, Agterberg JA, Rigter GM, Bakker JC. Bleeker WK, et al. Among authors: rigter gm. Artif Cells Blood Substit Immobil Biotechnol. 1995;23(4):461-8. doi: 10.3109/10731199509117962. Artif Cells Blood Substit Immobil Biotechnol. 1995. PMID: 7581832

8

Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE. de Smet BJ, et al. Blood. 1993 Jan 1;81(1):56-61. Blood. 1993. PMID: 8417802 Free article.

9

Protective effect of antithrombin III in acute experimental pancreatitis in rats.

Bleeker WK, Agterberg J, Rigter G, Hack CE, Gool JV. Bleeker WK, et al. Dig Dis Sci. 1992 Feb;37(2):280-5. doi: 10.1007/BF01308184. Dig Dis Sci. 1992. PMID: 1735347

10

Prevention of side effects by hemoglobin solutions; the selection of optimal test models, especially concerning thrombogenicity.

Bakker JC, Bleeker WK, Den Boer PJ, Biessels PT, Agterberg J, Rigter G, Holthuis JC, Mertens K. Bakker JC, et al. Artif Cells Blood Substit Immobil Biotechnol. 1994;22(3):577-85. doi: 10.3109/10731199409117886. Artif Cells Blood Substit Immobil Biotechnol. 1994. PMID: 7994377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters